We request that you authorize your proxy in advance of the upcoming Special Meeting of Stockholders which will take place virtually on August 8, 2025.
How do I authorize my proxy?
Option 1: By phone
Without a proxy card: call 1-877-864-5060 to speak with a proxy specialist Monday through Friday, 9am-9pm ET.
With a proxy card: call 1-800-690-6903 with a touch-tone phone to vote using an automated system.
Option 2: Online
Visit www.proxyvote.com and have the control number sent via mail or email in hand when accessing the website. There will be easy-to-follow directions to help you complete the electronic voting instruction form.
Option 3: By mail
Mark, sign and date your ballot and return it in the postage-paid envelope provided.
Frequently Asked Questions:
Why is there a special meeting?
The special meeting is being held to consider and vote on a proposal to authorize Ares Capital Corporation ("the Company"), with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value ("NAV") per share, subject to the limitations set forth in the proxy statement for the Special Meeting of Stockholders (including, without limitation, that the number of shares issued does not exceed 25% of the Company’s then outstanding common stock). If approved, the authorization would be effective for common stock issued during a twelve-month period expiring on the anniversary of the date of this Special Meeting of Stockholders.
Why vote for the proposal?
There are no immediate plans to issue any shares of common stock below NAV. Rather, during periods of significant market disruption, incremental capital may be required quickly to take advantage of favorable investment opportunities. Ares Capital Corporation is seeking stockholder approval now to provide flexibility in the event the Company believes it is needed in future.
Has ARCC asked for this authorization and used it in the past?
Stockholders have approved the Company's request to authorize the issuance of shares of its common stock below NAV on terms similar to what is being requested herein for each of the last 16 years, and has only used this approval one time to complete the acquisition of Allied Capital during a period of market disruption and volatility in 2009-2010. As described in further detail in the previously distributed proxy materials, this acquisition was transformational and accretive to the Company and its stockholders. We believe having this authorization is critical in allowing us to find opportunities to build stockholder value through all market conditions.
How can I learn more?
Please refer to the Notice of Meeting and Proxy Statement and Shareholder Letter for additional information.